Results 51 to 60 of about 3,746,463 (320)
The Korean Journal of Internal Medicine, 2020 Biological disease-modifying antirheumatic drugs (bDMARDs) are highly effective agents for the treatment of inf lammatory arthritis; however, they also possess a potential risk for serious infection.
Eun-Jung Park +5 more
semanticscholar +1 more source
Current issues in the management of patients with HIV infection and rheumatic diseases
Современная ревматология, 2021 According to experts, the human immunodeficiency virus (HIV) epidemic has a steady downward trend, but the attention of the medical community to this problem is not waning.
G. I. Gridneva, B. S. Belov
doaj +1 more source
The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults
Cleveland Clinic journal of medicine, 2020 Patients with immunocompromising conditions are at higher risk of vaccine-preventable infections. Further, those receiving immunosuppressive disease-modifying antirheumatic drugs (DMARDs) can have variable responses to vaccines depending on which vaccine
Alvin Lee Day, K. Winthrop, J. Curtis
semanticscholar +1 more source
Indian Journal of Rheumatology, 2017 Rheumatoid arthritis (RA) is a chronic, disabling inflammatory arthritis often treated with a variety of disease-modifying antirheumatic drugs (DMARDs), whether conventional synthetic DMARDs (csDMARDs), targeted synthetic DMARDs (tsDMARDs), or biological
Abhishek Zanwar +6 more
doaj +1 more source
Mode of Action of Antirheumatic Drugs [PDF]
BMJ, 1971 The concentrations of free and protein-bound L-tryptophan were measured in sera from normal subjects, patients with rheumatoid arthritis, pregnant women, and patients with jaundice. In the patients with rheumatoid arthritis receiving treatment with one or more antirheumatic drugs the percentage of the amino-acid bound to the circulating proteins was ...
P. D. Dawkins +3 more
openaire +3 more sources
The safety of antirheumatic drugs
Deutsches Ärzteblatt international, 2022 Drug therapy for rheumatic diseases has changed fundamentally in recent decades with the introduction of many new agents. As these drugs may have to be taken for many years, and many of them are of similar efficacy, their safety profiles play an important role in therapeutic decisionmaking.This review is based on pertinent literature retrieved by a ...
Johanna, Mucke +2 more
openaire +2 more sources
Arthritis care & research, 2020 Seropositivity for anti–citrullinated protein antibody (ACPA)/rheumatoid factor (RF) in rheumatoid arthritis (RA) is associated with increased overall mortality; however, the association between antibody titers and mortality is not well established ...
E. Alemao +3 more
semanticscholar +1 more source
JMIR Serious Games, 2022 BackgroundPatients’ implicit attitudes toward medication need and concerns may influence their adherence. Targeting these implicit attitudes by combining game-entertainment with medication-related triggers might improve medication
Bart PH Pouls +4 more
doaj +1 more source
Annals of the Rheumatic Diseases, 2016 A European League Against Rheumatism (EULAR) task force was established to define points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Carina Götestam Skorpen +19 more
semanticscholar +1 more source
Frontiers in Pharmacology, 2020 Mesenchymal stem cell (MSC)–based articular regeneration might be beneficial for both protecting and rebuilding cartilaginous tissues in the management of rheumatoid arthritis. However, it is unclear how current immunosuppressive strategies influence the
Shuang Liu +3 more
doaj +1 more source